Munafa Stock Market Course + Intraday & FNO calls 
Pacira Pharmaceuticals (PCRX) Technical (Analysis) Reports Pacira Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Pacira Pharmaceuticals (PCRX)
Technical Analysis Report for NASDAQ stock PCRX Pacira Pharmaceuticals. Dated: 10 Jul 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PCRX Pacira Pharmaceuticals then click here. or read Experts views on Pacira Pharmaceuticals or Forecast & share price targets of Pacira Pharmaceuticals
Pacira Pharmaceuticals Opened at 25.50 and Closed at: 25.47, which is -0.12% of previous session's close. It moved within a range of 24.90 and 25.95
The session was a Bearish session with an average volume of 180287, which is -72.49% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
A Golden cross was found 8 days back on mid term averages
A Golden cross was found 7 days back on long term averages
Support for tomorrow is 24.66 and resistance for tomorrow is 25.71
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 24.93, 24.39 resistance for tomorrow's hourly charts is 25.98, 26.49
10 Day SMA for Pacira Pharmaceuticals (PCRX) is 25.41 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Pacira Pharmaceuticals (PCRX) is 24.27 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Pacira Pharmaceuticals (PCRX) is 23.72 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 23.5 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Pacira Pharmaceuticals is 23.36 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Pacira Pharmaceuticals is at 24.27 and 200 DMA is at 23.36, while 50 DMA and 100 DMA are at 23.72 and 23.5 respectively
Pacira Pharmaceuticals (PCRX) moving average of 20 SMA is at 24.27 and 20 EMA is at 24.63
| Date | Closing Price | 20 SMA | 20 EMA |
| 10 Fri Jul | 25.47 | 24.27 | 24.63 |
| 09 Thu Jul | 25.50 | 24.17 | 24.54 |
| 08 Wed Jul | 25.54 | 24.06 | 24.44 |
| 07 Tue Jul | 25.82 | 23.92 | 24.32 |
| 06 Mon Jul | 25.59 | 23.77 | 24.16 |
| 02 Thu Jul | 25.39 | 23.62 | 24.01 |
Pacira Pharmaceuticals (PCRX) moving average of 50 SMA is at 23.72 and 50 EMA is at 23.98
| Date | Closing Price | 50 SMA | 50 EMA |
| 10 Fri Jul | 25.47 | 23.72 | 23.98 |
| 09 Thu Jul | 25.50 | 23.72 | 23.92 |
| 08 Wed Jul | 25.54 | 23.72 | 23.86 |
| 07 Tue Jul | 25.82 | 23.72 | 23.79 |
| 06 Mon Jul | 25.59 | 23.69 | 23.71 |
| 02 Thu Jul | 25.39 | 23.68 | 23.63 |
Pacira Pharmaceuticals (PCRX) moving average of 100 SMA is at 23.5 and 100 EMA is at 23.69
| Date | Closing Price | 100 SMA | 100 EMA |
| 10 Fri Jul | 25.47 | 23.5 | 23.69 |
| 09 Thu Jul | 25.50 | 23.47 | 23.65 |
| 08 Wed Jul | 25.54 | 23.43 | 23.61 |
| 07 Tue Jul | 25.82 | 23.39 | 23.57 |
| 06 Mon Jul | 25.59 | 23.35 | 23.52 |
| 02 Thu Jul | 25.39 | 23.3 | 23.48 |
Pacira Pharmaceuticals (PCRX) moving average of 200 SMA is at 23.36 and 200 EMA is at 23.53
| Date | Closing Price | 200 SMA | 200 EMA |
| 10 Fri Jul | 25.47 | 23.36 | 23.53 |
| 09 Thu Jul | 25.50 | 23.36 | 23.51 |
| 08 Wed Jul | 25.54 | 23.37 | 23.49 |
| 07 Tue Jul | 25.82 | 23.37 | 23.47 |
| 06 Mon Jul | 25.59 | 23.38 | 23.45 |
| 02 Thu Jul | 25.39 | 23.38 | 23.43 |
Viking Therapeutics has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Viking Therapeutics, about 26.81% more returns!
Pacira Pharmaceuticals has performed better than Tiziana Life in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Repligen Corporation in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Redhill Biopharma in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Pulse Biosciences in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Ovid Therapeutics has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Ovid Therapeutics, about 5% more returns!
Pacira Pharmaceuticals has performed better than Orasure Technologies in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Nektar Therapeutics has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 9.84% more returns!
Pacira Pharmaceuticals has performed better than Microbot Medical in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Krystal Biotech has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Krystal Biotech, about 4.73% more returns!
Pacira Pharmaceuticals has performed better than Atossa Genetics in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Celldex Therapeutics has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 21.51% more returns!
Cellectar Biosciences has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Cellectar Biosciences, about 16.3% more returns!
Pacira Pharmaceuticals has performed better than Cytosorbents Corporation in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Cytokinetics Incorporated has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 13.49% more returns!
Dermira Inc has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Dermira Inc, about 1.34% more returns!
Pacira Pharmaceuticals has performed better than Dexcom Inc in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Guardant Health has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Guardant Health, about 13.19% more returns!
Pacira Pharmaceuticals has performed better than Henry Schein in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals Technical analysis of indicators
Price action analysis of Pacira Pharmaceuticals (PCRX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Pacira Pharmaceuticals in short term and the buy signal is strong.
Pacira Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Pacira Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Pacira Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 25.37 and Pacira Pharmaceuticals PCRX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Pacira Pharmaceuticals PCRX stock. Volume based technical analysis of Pacira Pharmaceuticals PCRX stock is negative.
Pacira Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock PCRX Pacira Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PCRX Experts View which covers a lot of information including buying and selling signals
PCRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Pacira Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Pacira Pharmaceuticals (PCRX) Technical (Analysis) Reports Pacira Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
